XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC


November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at the La Rural property, in the City of Buenos Aires.

Under the tagline “Cancer at the center of the community and science”, the congress featured the participation and presentations of national and international professionals, offering simultaneous sessions in the nine available rooms, which had an excellent attendance.

Our team participated with a large stand that allowed us to receive doctors, residents and patient associations from all over the country and deliver promotional literature about the laboratory and our Oncology Line products (especially our recent launches: Vetrano® palbociclib, Gombrich® cabacitaxel y Dalcara® sorafenib).

Once again, the synergy between Sales, Marketing and the Medical Department providing support was present.

26th ARGENTINE CONGRESS OF HEMATOLOGY organized by the Argentine Society of Hematology

Bioprofarma Bagó participated in the 26th Argentine Congress of Hematology 2023, which was held from November 1st to the 4th at its two venues: the Sheraton Hotel and the Costa Galana Hotel, in the City of Mar del Plata.

New Product Launch VETRANO®palbociclib

We are thrilled to present to our community the launch of the product VETRANO® palbociclib, for our Oncology Line.

New Product Lunch TSUMIS®Carfilzomib

Bioprofarma Bagó is pleased to present the launch of the product TSUMIS® carfilzomib, for its Hematology Line.